1. J. P. Brandel, C. A. Heath, M. W. Head, E. Levavasseur, R. Knight, J. L. Laplanche, J. P. Langeveld, J. W. Ironside, J. J. Hauw, J. Mackenzie, A. Alperovitch, R. G. Will, and S. Haik. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol, 65(3):249-56, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Blood Transfusion/adverse effects, Brain/pathology, Child, Creutzfeldt-Jakob Syndrome/*epidemiology/*genetics/pathology, Female, France/epidemiology, Great Britain/epidemiology, Humans, Male, Medical Records/statistics & numerical data, Middle Aged, PrPSc Proteins/metabolism, Questionnaires, Retrospective Studies, Risk Factors, Young Adult.



2. J. C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M. J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fievet, P. Barberger-Gateau, S. Engelborghs, P. De Deyn, I. Mateo, A. Franck, S. Helisalmi, E. Porcellini, O. Hanon, M. M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossu, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanche, J. F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alperovitch, M. Lathrop, and P. Amouyel. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet, 41(10):1094-9, 2009. Note: European Alzheimer's Disease Initiative InvestigatorsJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Alzheimer Disease/*genetics, Clusterin/*genetics, European Continental Ancestry Group/genetics, *Genetic Predisposition to Disease, *Genome-Wide Association Study, Haplotypes, Humans, Polymorphism, Single Nucleotide, Receptors, Complement 3b/*genetics.



3. J. S. Vidal, M. Vidailhet, P. Derkinderen, T. D. de Gaillarbois, C. Tzourio, and A. Alperovitch. Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry, 80(11):1271-4, 2009. Note: Journal ArticleEngland. [WWW]



4. J. P. Brandel, D. Salomon, J. J. Hauw, S. Haik, and A. Alperovitch. [Creutzfeldt-Jakob disease in patients before and after 80 years of age.]. Psychol Neuropsychiatr Vieil, 6(3):219-24, 2008. Note: English AbstractJournal ArticleFrance. [WWW]



5. J. S. Vidal, M. Vidailhet, A. Elbaz, P. Derkinderen, C. Tzourio, and A. Alperovitch. Risk factors of multiple system atrophy: a case-control study in French patients. Mov Disord, 23(6):797-803, 2008. Note: Journal ArticleUnited Statesofficial journal of the Movement Disorder Society. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Alcohol Drinking/epidemiology, Case-Control Studies, Disease Progression, Environmental Exposure, Female, Food Habits, France/epidemiology, Humans, Interviews as Topic, Life Style, Male, Middle Aged, Multiple System Atrophy/*epidemiology/etiology/prevention & control, Patient Selection, Questionnaires, Reference Values, Risk Factors.



6. S. J. Collins, P. Sanchez-Juan, C. L. Masters, G. M. Klug, C. van Duijn, A. Poleggi, M. Pocchiari, S. Almonti, N. Cuadrado-Corrales, J. de Pedro-Cuesta, H. Budka, E. Gelpi, M. Glatzel, M. Tolnay, E. Hewer, I. Zerr, U. Heinemann, H. A. Kretszchmar, G. H. Jansen, E. Olsen, E. Mitrova, A. Alperovitch, J. P. Brandel, J. Mackenzie, K. Murray, and R. G. Will. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain, 129(Pt 9):2278-87, 2006. Note: Journal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tEnglanda journal of neurology. [WWW] Keyword(s): 14-3-3 Proteins/cerebrospinal fluid, Adult, Age of Onset, Aged, Aged, 80 and over, Brain/pathology, Creutzfeldt-Jakob Syndrome/cerebrospinal fluid/*diagnosis/genetics, Electroencephalography/methods, Female, Genotype, Humans, Magnetic Resonance Imaging/methods, Male, Middle Aged, Polymorphism, Genetic/genetics, Prions/genetics, Protein Precursors/genetics, Sensitivity and Specificity, Time Factors.



7. P. Cowppli-Bony, C. Fabrigoule, L. Letenneur, K. Ritchie, A. Alperovitch, J. F. Dartigues, and B. Dubois. [Validity of the five-word screening test for Alzheimer's disease in a population based study]. Rev Neurol (Paris), 161(12 Pt 1):1205-12, 2005. Note: English AbstractJournal ArticleValidation StudiesFrance. [WWW] Keyword(s): Aged, Aged, 80 and over, Alzheimer Disease/*diagnosis, Female, Humans, Male, *Neuropsychological Tests.



8. A. Ladogana, M. Puopolo, E. A. Croes, H. Budka, C. Jarius, S. Collins, G. M. Klug, T. Sutcliffe, A. Giulivi, A. Alperovitch, N. Delasnerie-Laupretre, J. P. Brandel, S. Poser, H. Kretzschmar, I. Rietveld, E. Mitrova, P. Cuesta Jde, P. Martinez-Martin, M. Glatzel, A. Aguzzi, R. Knight, H. Ward, M. Pocchiari, C. M. van Duijn, R. G. Will, and I. Zerr. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64(9):1586-91, 2005. Note: Journal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Australia/epidemiology, Canada/epidemiology, Causality, Child, Creutzfeldt-Jakob Syndrome/classification/*mortality, Europe/epidemiology, Female, Genetic Predisposition to Disease/epidemiology, Geography, Humans, Iatrogenic Disease/epidemiology, Male, Middle Aged, Mortality/trends, Population Surveillance/methods, Prion Diseases/etiology/mortality, Sex Factors, World Health, Zoonoses/epidemiology/transmission.



9. S. Haik, J. P. Brandel, D. Salomon, V. Sazdovitch, N. Delasnerie-Laupretre, J. L. Laplanche, B. A. Faucheux, C. Soubrie, E. Boher, C. Belorgey, J. J. Hauw, and A. Alperovitch. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology, 63(12):2413-5, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain/pathology, Creutzfeldt-Jakob Syndrome/*drug therapy/mortality/pathology, Disease Progression, Drug Evaluation, Humans, Quinacrine/administration & dosage/adverse effects/*therapeutic use, Survival Analysis, Treatment Failure.



10. M. Pocchiari, M. Puopolo, E. A. Croes, H. Budka, E. Gelpi, S. Collins, V. Lewis, T. Sutcliffe, A. Guilivi, N. Delasnerie-Laupretre, J. P. Brandel, A. Alperovitch, I. Zerr, S. Poser, H. A. Kretzschmar, A. Ladogana, I. Rietvald, E. Mitrova, P. Martinez-Martin, J. de Pedro-Cuesta, M. Glatzel, A. Aguzzi, S. Cooper, J. Mackenzie, C. M. van Duijn, and R. G. Will. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain, 127(Pt 10):2348-59, 2004. Note: Journal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tEnglanda journal of neurology. [WWW] Keyword(s): Adolescent, Adult, Age Distribution, Age of Onset, Aged, Australia/epidemiology, Child, Codon/genetics, Creutzfeldt-Jakob Syndrome/genetics/mortality, Europe/epidemiology, Female, Gerstmann-Straussler-Scheinker Disease/genetics/mortality, Heterozygote, Humans, Iatrogenic Disease/epidemiology, Male, Middle Aged, Mutation, Population Surveillance/methods, Prion Diseases/genetics/*mortality, Prions/genetics, Proportional Hazards Models, Prospective Studies, Sex Distribution.



11. J. P. Brandel, M. Preece, P. Brown, E. Croes, J. L. Laplanche, Y. Agid, R. Will, and A. Alperovitch. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet, 362(9378):128-30, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Codon, Creutzfeldt-Jakob Syndrome/*genetics/*transmission, France, Great Britain, *Homozygote, Human Growth Hormone/*adverse effects, Humans, Iatrogenic Disease, Polymorphism, Genetic, PrPSc Proteins/*genetics, Risk Factors.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html